Sanofi ADR (SNYN)

871.23
+0.81(+0.09%)
  • वॉल्यूम:
    1,126
  • बोली/पुछे:
    858.75/970.00
  • दिन की रेंज:
    871.23 - 871.23

SNYN समीक्षा

पिछला बंद
870.42
दिन की रेंज
871.23-871.23
आय
44.35B
खुला
871.23
52 सप्ताह रेंज
759-1,111
ईपीएस
5.12
वॉल्यूम
1,126
मार्केट कैप
2.17T
लाभांश (यील्ड)
1.4368
(2.89%)
औसत वॉल्यूम (3एम)
1,809
पी/ई अनुपात
16.58
बीटा
0.416
1- वर्ष बदलाव
-18.73%
बकाया शेयर
1,247,405,732
अगली कमाई तिथि
-
Sanofi ADR पर आपकी भावना क्या है?
या
अभी बाज़ार बंद हैं। वोटिंग बाजार का समय के दौरान खुली है।

Sanofi ADR समाचार

Sanofi ADR विश्लेषण

Sanofi ADR कंपनी प्रोफाइल

Sanofi ADR कंपनी प्रोफाइल

क्षेत्र
हेल्थकेयर
कर्मचारी
95442
  • प्रकार:इक्विटी
  • बाज़ार:मेक्सिको
  • आईसआईन:US80105N1054
  • एस/न:80105N105

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

और पढ़ें

विश्लेषक मूल्य लक्ष्य

औसत64.00 (+39.07% ऊपर)
उच्च65.00
निम्न63.00
क़ीमत46.02
विश्लेषकों की संख्या3
मजबूत विक्रय
बेचना
तटस्थ
खरीदें
मजबूत खरीद
मजबूत खरीद
विश्लेषकों की आम सहमति

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजबेचनाबेचनामजबूत विक्रयमजबूत विक्रयमजबूत विक्रय
तकनीकी संकेतकखरीदेंमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय
सारांशतटस्थमजबूत विक्रयमजबूत विक्रयमजबूत विक्रयमजबूत विक्रय